onapristone extended release
1 product
1 abstract
Abstract
OATH trial: A phase II clinical trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer—Preliminary results.Org: Thomas Jefferson University Hospital, Abington Hospital-Jefferson Health, Gyn Onc Inst, Sidney Kimmel Medical College at Thomas Jefferson University, Thomas Jefferson University,
Product
ONA-XR